In a rare, longitudinal study, researchers from Aalto University and the University of Oulu tracked one person’s brain and behavioral activity for five months using brain scans and data from wearable devices and smartphones.
Selinexor by Karyopharm Therapeutics for Osteosarcoma: Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes